These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31128378)

  • 1. Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement.
    Kim S; Yun J; Kang DY; Park HJ; Jo EJ; Jung JW; Park HK; Park JW; Jee YK; Kang HR; Lee JM
    J Allergy Clin Immunol Pract; 2019; 7(8):2851-2853.e2. PubMed ID: 31128378
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-Reactivity Between Carbonic Anhydrase Inhibitor Confirmed by Lymphocyte Transformation Test: A Case of Methazolamide-Induced Toxic Epidermal Necrolysis.
    Sohn KH; Kim SH; Kang HR
    J Investig Allergol Clin Immunol; 2021 Oct; 31(5):455-456. PubMed ID: 33439124
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare case of topical methazolamide ophthalmic solution causing death due to toxic epidermal necrolysis.
    Shi L; Li M; Zhang F; Wang B; Yi X; Ding Y; Wang X
    Clin Exp Dermatol; 2018 Apr; 43(3):326-327. PubMed ID: 29330876
    [No Abstract]   [Full Text] [Related]  

  • 4. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women.
    Flach AJ; Smith RE; Fraunfelder FT
    Ophthalmology; 1995 Nov; 102(11):1677-80. PubMed ID: 9098261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901.
    Xu Y; Wu M; Sheng F; Sun Q
    Indian J Ophthalmol; 2015 Jul; 63(7):623-4. PubMed ID: 26458485
    [No Abstract]   [Full Text] [Related]  

  • 6. Methazolamide-induced Stevens-Johnson syndrome: a warning!
    Cotter JB
    Arch Ophthalmol; 1998 Jan; 116(1):117. PubMed ID: 9445224
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic epidermal necrolysis induced by methazolamide in a Chinese-Korean man carrying HLA-B*59:01.
    Shu C; Shu D; Tie D; Yu M; Zhang R; Wang T; Dong Q; Sun Q; Mao X; Yan Y
    Int J Dermatol; 2015 Nov; 54(11):1242-5. PubMed ID: 25970075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome induced by acetazolamide.
    Her Y; Kil MS; Park JH; Kim CW; Kim SS
    J Dermatol; 2011 Mar; 38(3):272-5. PubMed ID: 21342230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome induced by methazolamide treatment.
    Shirato S; Kagaya F; Suzuki Y; Joukou S
    Arch Ophthalmol; 1997 Apr; 115(4):550-3. PubMed ID: 9109770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.
    Yang F; Xuan J; Chen J; Zhong H; Luo H; Zhou P; Sun X; He L; Chen S; Cao Z; Luo X; Xing Q
    Pharmacogenomics J; 2016 Feb; 16(1):83-7. PubMed ID: 25918017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kim SH; Kim M; Lee KW; Kim SH; Kang HR; Park HW; Jee YK
    Pharmacogenomics; 2010 Jun; 11(6):879-84. PubMed ID: 20504258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Jee YK; Kim S; Lee JM; Park HS; Kim SH
    Clin Exp Allergy; 2017 Jul; 47(7):972-974. PubMed ID: 28295713
    [No Abstract]   [Full Text] [Related]  

  • 13. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report.
    Ogasawara K; Tomitsuka N; Kobayashi M; Komoribayashi N; Fukuda T; Saitoh H; Inoue T; Ogawa A
    Neurol Med Chir (Tokyo); 2006 Mar; 46(3):161-3. PubMed ID: 16565588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid.
    Jiang YY; Nguyen GH; Jin HZ; Zeng YP
    Int J Dermatol; 2018 Apr; 57(4):494-496. PubMed ID: 29359334
    [No Abstract]   [Full Text] [Related]  

  • 15. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors.
    Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I
    Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255
    [No Abstract]   [Full Text] [Related]  

  • 16. Methazolamide Associated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in a Female of Caucasian Descent.
    Baluch A; Chohan MR; Warda K; Sippy R; Sandhu J
    Cureus; 2022 Feb; 14(2):e21864. PubMed ID: 35155038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing side effects of carbonic anhydrase inhibitors.
    Lichter PR
    Ophthalmology; 1981 Mar; 88(3):266-9. PubMed ID: 7231916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic reactions to carbonic anhydrase inhibitors.
    Fraunfelder FT; Meyer SM; Bagby GC; Dreis MW
    Am J Ophthalmol; 1985 Jul; 100(1):79-81. PubMed ID: 4014383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.